Join the Oncology Voice Network. Join for Free
The HIGH FIVE Challenge
Mel Robbins High Five Habit Tom Caravela MSL Talk Podcast High Five Challenge

The HIGH FIVE Challenge


Share This Article


Summary

In this episode, Tom Caravela delves into the transformative power of Mel Robbins' high five habit. He begins by introducing Mel Robbins and her background, then unpacks the concept and practical application of the high five habit. Tom discusses research and studies that validate its effectiveness, highlighting how it can positively impact daily intentions and mindset. The episode encourages listeners to undertake the high five challenge and invites them to share their personal experiences with this practice.

Tom Caravela, Managing Director of The Carolan Group and Host of the MSL Talk Podcast introduces the HIGH FIVE Habit and the HIGH FIVE Challenge.

Tom shares…

πŸ‘‰ Insights on the new book by @Mel Robbins, The High Five Habit

πŸ‘‰ What the High Five Habit is and how it works

πŸ‘‰ The research behind the movement and why you should consider it

πŸ‘‰ An invitation to the High Five Challenge

Click for Source
Mel Robbins, High Five Habit, Tom Caravela, MSL Talk Podcast, High Five Challenge

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Why Relationships Define Medical Affairs Leadership
OVN Avatar Kirk Shepard

Why Relationships Define Medical Affairs Leadership

Podcast
How Medical Affairs Professionals Should Engage with Digital Opinion Leaders
Partner Avatar MSL Talk: Tom Caravela, Paul Ward

How Medical Affairs Professionals Should Engage with Digital Opinion Leaders

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Podcast
Hiring Managers Beware: Reverse Rejection Explained!
Partner Avatar Michael Pietrack

Hiring Managers Beware: Reverse Rejection Explained!

Article
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies β€” and a Call to Candidates
OVN Avatar Jamie Riley

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies β€” and a Call to Candidates

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts KΓ₯gedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Explore OVN